Search results for "PEG"

showing 10 items of 460 documents

Functionnalized magnetite nanoparticles for bimodal imaging MRI/PET

2015

Functionalized magnetite nanoparticles for bimodal MRI/PET imagingSuperParamagnetic Iron Oxide Nanoparticles (SPIONs) have been widely studied in the biomedical field due to their promising application as nanodrugs and MRI (Magnetic Resonance Imaging) contrast agents (T2). In this study, magnetite (Fe3O4) nanoparticles have been developed for use as contrast agents for MRI/PET (Positron emission tomography) double imaging. First, functionalized stable superparamagnetic SPIONs have been synthesized in a continuous hydrothermal reactor. During the synthesis, hydrophilic agents (citric acid, LDOPA, DHCA and PHA) have been grafted on the surface of the nanoparticles. The functionalization of th…

GraftingHydrothermal continuFe3O4FonctionnalisationHydrothermal continuous synthesisCatécholsPEG[PHYS.PHYS.PHYS-CHEM-PH] Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph]SPIONsPETTEPFunctionalizationMacrocyclesMRIGreffageIRM
researchProduct

Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucle…

2015

HBsAgHepatologyChronic hepatitisHbeag negativebusiness.industryGenotypeGastroenterologymedicinebusinessInterim analysisVirologyPeginterferon alfa-2amedicine.drugDigestive and Liver Disease
researchProduct

LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND…

2011

HCV Cirrhosis SVR PEG IFN PORTAL HYPERTENSION
researchProduct

Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV

2012

HCV HCC PEG IFN RBV
researchProduct

Vincoli universali del linguaggio e impegni deontici nella costruzione della realtà sociale

2009

Hegel Searle linguaggio razionalità ontologia sociale coscienza morale impegni deontici dialettica del riconoscimento realtà istituzionale intenzionalità collettiva.
researchProduct

Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations

2013

SummaryThe addition of protease inhibitors, boceprevir or telaprevir, to peginterferon+ribavirin (PegIFN/RBV) increases the frequency as well as the severity, and hence, clinical relevance of anemia, which has now become one of the major complications associated with triple therapy. Most significant factors associated with anemia in patients receiving triple therapy include older age, lower body mass index (BMI), advanced fibrosis, and lower baseline hemoglobin. The variability in inosine triphosphate pyrophosphatase (ITPA) gene, which encodes a protein that hydrolyses inosine triphosphate (ITP), has been identified as an essential genetic factor for anemia both in dual and triple therapy. …

Hemolytic anemiamedicine.medical_specialtyAnemiaGastroenterologyTelaprevirTelaprevirchemistry.chemical_compoundhemic and lymphatic diseasesInternal medicineBoceprevirRibavirinMedicineBoceprevirHepatologyHepatitis C virusbusiness.industryRibavirinAnemiamedicine.diseaseTransplantationProtease inhibitorchemistryErythropoietinImmunologyITPAbusinessPegylated interferonEpoietinmedicine.drugJournal of Hepatology
researchProduct

All-trans retinoic acid for treatment of chronic hepatitis C

2008

Background/Aims: In vitro studies in the subgenomic hepatitis C virus (HCV) replicon system have identified all-trans retinoic acid (ATRA) as a potential therapeutic against hepatitis C. Thus, the antiviral potential of this drug should be assessed in vivo. Methods: Twenty highly treatment experienced serotype 1 patients with non-response to conventional or pegylated interferon-α (Peg-/IFN-α) and ribavirin were randomly assigned to 12 weeks of monotherapy with ATRA (group A) or a combination of ATRA and PegIFN-α2a (group B). HCV RNA was assessed by bDNA assay and if negative by highly sensitive polymerase chain reaction. Results: During treatment, five of 10 patients in group A had a drop o…

HepatitisHepatologybiologyorganic chemicalsRibavirinHepacivirusHepatitis C virusvirus diseasesHepatitis CPharmacologymedicine.diseasebiology.organism_classificationmedicine.disease_causeVirologybiological factorschemistry.chemical_compoundchemistryPegylated interferonmedicineBDNA testneoplasmsViral loadmedicine.drugLiver International
researchProduct

PEG IFN alfa-2a vs. alfa-2b: And the winner is …?

2009

Abstract Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team. N Engl J Med 2009 Aug 6;361(6):580–93. Background Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C virus (HCV) infection. However, these regimens have not been adequately compared. Methods At 118 sites, patients who had HCV genotype 1 infection and who had not …

Hepatitismedicine.medical_specialtyHepatologybusiness.industryRibavirinvirus diseasesHepatitis Cmedicine.diseaseGastroenterologyChronic hepatitis HCV Head-to-head studies Pegylated interferons Ribavirindigestive system diseasesConfidence intervalSurgeryRegimenchemistry.chemical_compoundPharmacotherapystomatognathic systemchemistryTolerabilityInternal medicineMedicinebusinessAdverse effectJournal of Hepatology
researchProduct

Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy

2014

This paper deal with the synthesis and characterization of PEGylated squalene-grafted-inulin amphiphile capable of self-assembling and self-organizing into nanocarriers once placed in aqueous media. It was exploited as coating agent for obtaining doxorubicin loaded superparamagnetic iron oxide nanoparticles (SPIONs) endowed with stealth like behavior and excellent physicochemical stability. Inulin was firstly modified in the side chain with primary amine groups, followed in turn by conjugation with squalenoyl derivatives through common amidic coupling agents and PEGylation by imine linkage. Polymer coated SPIONs were so obtained by spontaneous self-assembling of inulin copolymer onto magnet…

Hydrodynamic radiusCell SurvivalPolymersSurface PropertiesPharmaceutical ScienceTherapeutic indexSpectroscopy Fourier Transform InfraredAmphiphileZeta potentialmedicineSPIONs Inulin copolymer Doxorubicin Magnetic targeting Squalene PegylatedHumansOrganic chemistryDoxorubicinParticle SizeMagnetite NanoparticlesDrug CarriersAntibiotics AntineoplasticMolecular StructureChemistryInulinGeneral MedicineHCT116 CellsCombinatorial chemistryDrug LiberationDoxorubicinDrug deliveryMicroscopy Electron ScanningPEGylationNanocarriersBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Purification, crystallization and preliminary X-ray studies of sylvaticin, an elicitin-like protein from Pythium sylvaticum.

2003

Sylvaticin belongs to the elicitin family. These 10 kDa oomycetous proteins induce a hypersensitive response in plants, including necrosis and cell death, but subsequently leading to a non-specific systemic acquired resistance (SAR) against other pathogens. Sylvaticin has been crystallized using PEG 2000 MME as a precipitant agent in the presence of nickel chloride. The crystals belong to space group C2, with unit-cell parameters a = 99.29, b = 25.67, c = 67.45 A, beta = 99.66 degrees. Diffraction data were recorded to 2.1 A resolution at a synchrotron-radiation source.

Hypersensitive responseStereochemistryProtein ConformationPythiumBiologyCrystallography X-Raylaw.inventionPolyethylene GlycolsProtein structureStructural BiologylawNickelPEG ratioCrystallizationFuransAlgal ProteinsX-rayProteinsElicitinGeneral Medicinebiology.organism_classificationCrystallographySolventsPythium sylvaticumSystemic acquired resistanceSynchrotronsActa crystallographica. Section D, Biological crystallography
researchProduct